Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
I. Barta (Budapest, Hungary), B. Gábor (Budapest, Hungary), B. Simon (Budapest, Hungary), C. Páska (Budapest, Hungary), R. Szvatek (Budapest, Hungary), G. Böszörményi-Nagy (Budapest, Hungary), É. Vizi (Budapest, Hungary), B. Antus (Budapest, Hungary). Effect of CPAP therapy on cardiovascular risk in severe obstructive sleep apnea:the MMP:TIMP balance. 4156

Member's Comments

No comment yet.

Related content which might interest you: Relationship between aldosterone and the metabolic syndrome in patients with obstructive sleep apnea: Effect of continuous positive airway pressure treatment Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013 Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012 The effect of CPAP treatment on Galectin-3 level in patients with severe obstructive sleep apnea Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018 Effect of compliance to continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 320s Year: 2007 The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018 Endothelial and systemic inflammation in obstructive sleep apnea syndrome: Impact of CPAP therapy on CRP plasma levels Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010 Effect of continuous positive airway pressure (CPAP) treatment on proangiogenic factors of angiogenesis in obstructive sleep apnea (OSA) patients Source: Eur Respir J 2005; 26: Suppl. 49, 39s Year: 2005 Role of CPAP treatment in elderly with moderate obstructive sleep apnea Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients? Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 Combination between sleep apnoea and COPD: a synergistic risk for cardiovascular diseases? Source: Sleep and Breathing Conference 2017 Year: 2017 Effect of continuous positive airway pressure therapy on metabolic control in patients with morbid obesity and obstructive sleep apnoea Source: Annual Congress 2013 –Burn after reading: inflammation in sleep disordered breathing Year: 2013 Antioxidant status in obstructive sleep apnea: no influence of one night continuous airway pressure therapy Source: Eur Respir J 2006; 28: Suppl. 50, 574s Year: 2006 Effect of continuous positive airway pressure treatment (CPAP) in angiogenic growth factors‘ expression in patients with COPD and obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 Effects of CPAP treatment on physical fitness in patients with obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2003; 22: Suppl. 45, 97s Year: 2003 Fibrinogen level in patients with severe obstructive sleep apnoea syndrome (OSAS). Effect of n-CPAP therapy Source: Eur Respir J 2001; 18: Suppl. 33, 216s Year: 2001 Effect of ventilation therapy on mortality rate among obesity hypoventilation syndrome and obstructive sleep apnoea patients Source: ERJ Open Res, 6 (2) 00101-2019; 10.1183/23120541.00101-2019 Year: 2020 Cardiovascular and metabolic effects of CPAP in obese obstructive sleep apnoea patients Source: Eur Respir J 2008; 31: 223-225 Year: 2008 CPAP in the elderly with non-severe obstructive sleep apnea: effect on cardiovascular events and somnolence. Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment Year: 2017 Physical activity in obstructive sleep apnea (OSA) patients with high cardiovascular risk Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise Year: 2010 CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD Source: Eur Respir J 2010; 35: 132-137 Year: 2010